1. PROTAC Epigenetics
  2. PROTACs Epigenetic Reader Domain
  3. KBD-1

KBD-1 is a muscle-specific BRD4 PROTAC degrader with human KDs of 27.04 nM and 37.36 µM against BRD4 and KLHL4L, respectively. KBD-1 recruits the muscle-specific E3 ligase KLHL41, mediating Cullin-RING ligase (CRL)-dependent ubiquitination and proteasome degradation of BRD4. KBD-1 can be used for the research of myosarcoma.
(Pink: BRD4 ligand (HY-78695); Blue: KLHL41 ligand (HY-184150); Black: linker).

For research use only. We do not sell to patients.

KBD-1

KBD-1 Chemical Structure

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Top Publications Citing Use of Products

View All PROTACs Isoform Specific Products:

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

KBD-1 is a muscle-specific BRD4 PROTAC degrader with human KDs of 27.04 nM and 37.36 µM against BRD4 and KLHL4L, respectively. KBD-1 recruits the muscle-specific E3 ligase KLHL41, mediating Cullin-RING ligase (CRL)-dependent ubiquitination and proteasome degradation of BRD4. KBD-1 can be used for the research of myosarcoma[1]. (Pink: BRD4 ligand (HY-78695); Blue: KLHL41 ligand (HY-184150); Black: linker).

IC50 & Target[1]

BRD4

 

In Vitro

KBD-1 directly interacts with purified recombinant KLHL41 protein with a KD of 37.36 µM[1].
KBD-1 (20 μM; 12 h) completely degrades BRD4 in RH30 human rhabdomyosarcoma cells[1].
KBD-1 (20 μM) induces BRD4 degradation in RH30 human rhabdomyosarcoma cells via Cullin-RING ligase (CRL)-mediated ubiquitination and proteasomal degradation[1].
KBD-1 (20 μM; 24 h) induces BRD4 degradation specifically in RD and RH30 human rhabdomyosarcoma cells (KLHL41-expressing) but not in OV90, A549, SW480, or HeLa non-muscle cancer cell lines[1].
KBD-1 (40 μM; 24 h) induces cytotoxicity specifically in RD and RH30 human rhabdomyosarcoma cells but not in OV90, A549, SW480, or HeLa non-muscle cancer cell lines, with an IC50 of 20 μM in myosarcoma cells[1].
KBD-1 (20 μM; 12 h)-induced BRD4 degradation in RH30 human rhabdomyosarcoma cells is dependent on KLHL41 expression[1].
KBD-1 (20 μM; 12 h) induces BRD4 degradation in HeLa human cervical adenocarcinoma cells only when KLHL41 is overexpressed, confirming KLHL41-dependent activity[1].
KBD-1 induces BRD4 degradation in differentiated C2C12 mouse myocytes (high KLHL41 expression) but not in undifferentiated C2C12 myoblasts (low KLHL41 expression)[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis[1]

Cell Line: RH30 human rhabdomyosarcoma cells
Concentration: 20 μM
Incubation Time: 12 h
Result: Achieved complete BRD4 degradation at 20 μM after 12 h treatment.

Western Blot Analysis[1]

Cell Line: RD and RH30 human rhabdomyosarcoma cells, OV90, A549, SW480, HeLa non-muscle cancer cell lines
Concentration: 20 μM
Incubation Time: 24 h
Result: Induced BRD4 degradation in KLHL41-expressing RD and RH30 myosarcoma cell lines, but did not induce BRD4 degradation in non-muscle related cancer cell lines (OV90, A549, SW480, HeLa).

Cell Viability Assay[1]

Cell Line: RD and RH30 human rhabdomyosarcoma cells, OV90, A549, SW480, HeLa non-muscle cancer cell lines
Concentration: 40 μM
Incubation Time: 24 h
Result: Exhibited cytotoxicity only in RD and RH30 myosarcoma cell lines at 40 μM, with IC50 values of 20 μM, while showing no cytotoxicity in non-muscle related cancer cell lines even at 40 μM.

Western Blot Analysis[1]

Cell Line: RH30 human rhabdomyosarcoma cells (KLHL41 knockdown)
Concentration: 20 μM
Incubation Time: 12 h
Result: Successfully induced BRD4 degradation in RH30 cells prior to KLHL41 knockdown, but BRD4 degradation was disturbed after KLHL41 knockdown.

Western Blot Analysis[1]

Cell Line: HeLa human cervical adenocarcinoma cells (KLHL41 overexpression)
Concentration: 20 μM
Incubation Time: 12 h
Result: Did not induce BRD4 degradation in HeLa cells prior to KLHL41 overexpression, but successfully degraded BRD4 after KLHL41 overexpression.
Molecular Weight

745.33

Formula

C41H41ClN8O2S

SMILES

O=C(NCC1=CC=C([C@@H]2OCC[C@H]2CNCC3=CNN=C3C4=CC=CC=C4)C=C1)C[C@H]5C6=NN=C(C)N6C7=C(C(C)=C(C)S7)C(C8=CC=C(Cl)C=C8)=N5

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
KBD-1
Cat. No.:
HY-184151
Quantity:
MCE Japan Authorized Agent: